ArticleExperimental neurology2010
Dynamic quantification of host Schwann cell migration into peripheral nerve allografts.
Article in Experimental neurology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 28 citations in OpenAlex.
- Evaluation of two methods to isolate Schwann cells from murine sciatic nerve.Journal of neuroscience methods · 2020Article
- Analysis of Schwann Cell Migration and Axon Regeneration Following Nerve Injury in the Sciatic Nerve Bridge.Frontiers in molecular neuroscience · 2019Article
- Comparing Processed Nerve Allografts and Assessing Their Capacity to Retain and Release Nerve Growth Factor.Annals of plastic surgery · 2018Article
- Nerve stepping stone has minimal impact in aiding regeneration across long acellular nerve allografts.Muscle & nerve · 2018Article
- Robust Axonal Regeneration in a Mouse Vascularized Composite Allotransplant Model Undergoing Delayed Tissue Rejection.Hand (New York, N.Y.) · 2016Article
- The curious ability of polyethylene glycol fusion technologies to restore lost behaviors after nerve severance.Journal of neuroscience research · 2016Review
- Comparison of acellular nerve allograft modification with Schwann cells or VEGF.Hand (New York, N.Y.) · 2015Article
- Alternatives to sural nerve grafts in the upper extremity.Hand (New York, N.Y.) · 2015Article
- Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence.Experimental neurology · 2013Article
- Nerve regeneration in rat limb allografts: evaluation of acute rejection rescue.Plastic and reconstructive surgery · 2013Article
- Clinical strategies to enhance nerve regeneration in composite tissue allotransplantation.Hand clinics · 2011Review
- A novel model for evaluating nerve regeneration in the composite tissue transplant: the murine heterotopic limb transplant.Hand (New York, N.Y.) · 2011Article
- Nerve allotransplantation as it pertains to composite tissue transplantation.Hand (New York, N.Y.) · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
Host Schwann cell (SC) migration into nerve allografts is the limiting factor in the duration of immunosuppression following peripheral nerve allotransplantation, and may be affected by different immunosuppressive regimens. Our objective was to compare SC migration patterns between clinical and experimental immunosuppression regimens both over time and at the harvest endpoint. Eighty mice that express GFP under the control of the Schwann cell specific S100 promoter were engrafted with allogeneic, nonfluorescent sciatic nerve grafts. Mice received immunosuppression with either tacrolimus (FK506), or experimental T-cell triple costimulation blockade (CSB), consisting of CTLA4-immunoglobulin fusion protein, anti-CD40 monoclonal antibody, and anti-inducible costimulator monoclonal antibody. Migration of GFP-expressing host SCs into wild-type allografts was assessed in vivo every 3 weeks until 15 weeks postoperatively, and explanted allografts were evaluated for immunohistochemical staining patterns to differentiate graft from host SCs. Immunosuppression with tacrolimus exhibited a plateau of SC migration, characterized by significant early migration (< 3 weeks) followed by a constant level of host SCs in the graft (15 weeks). At the endpoint, graft fluorescence was decreased relative to surrounding host nerve, and donor SCs persisted within the graft. CSB-treated mice displayed gradually increasing migration of host SCs into the graft, without the plateau noted in tacrolimus-treated mice, and also maintained a population of donor SCs at the 15-week endpoint. SC migration patterns are affected by immunosuppressant choice, particularly in the immediate postoperative period, and the use of a single treatment of CSB may allow for gradual population of nerve allografts with host SCs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.